Anesthesiology | Daniel J. Rosenkrans, MD March 28, 2025 | 1.00 Credits | 28:25

The goal of this program is to improve management of perioperative conduction disorders. After hearing and assimilating this program, the clinician will be better able to:

1. Optimize management of atrial fibrillation.
2. Administer phenylephrine in patients with unstable arrhythmia.

Anesthesiology | Lavinia M. Kolarczyk, MD March 28, 2025 | 1.25 Credits | 34:55

The goal of this program is to improve use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs). After hearing and assimilating this program, the clinician will be better able to:

1. Cite guidelines on use of ACE inhibitors and ARBs in patients undergoing surgery.
2. Use phenylephrine in patients with perioperative refractory hypotension.
3. Explain serotonin syndrome in treatment of refractory hypotension for patients on selective serotonin reuptake inhibitors.

Family Medicine | Eric Rodriguez, MD, MPH March 28, 2025 | 1.00 Credits | 30:45

The goal of this program is to improve the management of Alzheimer disease (AD). After hearing and assimilating this program, the clinician will be better able to:

1. Analyze biomarkers for differential diagnosis of AD.
2. Recognize risk factors associated with use of monoclonal antibodies in AD.

Family Medicine | Alaina P. Vidmar, MD March 28, 2025 | 1.00 Credits | 35:20

The goal of this program is to improve puberty evaluation. After hearing and assimilating this program, the clinician will be better able to:

1. Review the normal sequence of pubertal events.
2. Treat central precocious puberty.
3. Optimize management of delayed puberty in adolescents.

Gastroenterology | Suresh Pola, MD March 21, 2025 | 0.75 Credits | 21:45

The goal of this program is to improve diagnosis and management of inflammatory bowel disease in patients who identify as lesbian, gay, bisexual, transgender, queer (LGBTQ+). After hearing and assimilating this program, the clinician will be better able to:

1. Communicate with LGBTQ+ patients in a respectful and affirming manner.
2. Develop and implement individualized treatment plans that address the specific needs and preferences of LGBTQ+ patients.

Oncology | Frank Furnari, PhD March 21, 2025 | 0.75 Credits | 20:03

The goal of this program is to improve knowledge about the potential applications of induced pluripotent stem cells (iPSC) for the study of central nervous system (CNS) tumors. After hearing and assimilating this program, the clinician will be better able to:

1. Summarize the potential applications of iPSCs for the study of CNS tumors.

Oncology | Lisa Anne Feldman, MD, PhD March 21, 2025 | 0.50 Credits | 17:23

The goal of this program is to improve use of chimeric antigen receptor T cell (CAR T) therapy for leptomeningeal disease from primary brain tumors. After hearing and assimilating this program, the clinician will be better able to:

1. Recognize the challenges and limitations of conventional treatments for leptomeningeal disease.
2. Identify potential targets for CAR T cell therapy to use in treatment of primary brain tumors.

Oncology | Aram Modrek, MD, PhD March 21, 2025 | 0.50 Credits | 14:09

The goal of this program is to improve management of radiation resistance for CNS tumors. After hearing and assimilating this program, the clinician will be better able to:

1. Appraise the role of radiation resistance in the management of tumors involving the CNS.
2. Apply knowledge of radiation resistance mechanisms to predict treatment outcomes and develop personalized treatment strategies.

Orthopaedics | Nicole C. Wright, PhD, MPH March 21, 2025 | 1.25 Credits | 34:45

The goal of this program is to improve management of osteoporosis by addressing racial differences and disparities in care. After hearing and assimilating this program, the clinician will be better able to:

1. Cite potential pitfalls of the current definitions and clinical criteria for osteoporosis.
2. Compare risk for osteoporosis among different racial and ethnic groups.
3. Identify factors that may contribute to disparities in osteoporosis management and fracture outcomes among different racial and ethnic groups.

Gastroenterology | Anna Evans Phillips, MD March 21, 2025 | 1.25 Credits | 34:55

The goal of this program is to improve diagnosis and management of exocrine pancreatic insufficiency. After hearing and assimilating this program, the clinician will be better able to:

1. Use appropriate diagnostic tests to identify exocrine pancreatic insufficiency.
2. Recognize the importance of appropriate dosing and titration strategies for pancreatic enzyme replacement therapy.
3. Identify potential adverse effects and complications of pancreatic enzyme replacement therapy.